Intravenous Albumin in Patients With Cirrhosis: Evaluation of Practice Patterns and Secular Trends of Usage in Ontario 2000 to 2017.

David Mario RodriguesMaya DjerbouaJennifer A Flemming

Published in: Journal of the Canadian Association of Gastroenterology (2020)

IV albumin use has doubled over two decades and is frequently used in hospitalized patients with cirrhosis with only 50% being prescribed for evidence-based indications. These results highlight the impact of cirrhosis on albumin use and highlight potential quality improvement opportunities.

Keyphrases

quality improvement
high dose
patient safety
low dose
risk assessment
human health